Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "thrifty substrate" hypothesis. Diabetes Care 2016;39: 1108-1114

Research output: Contribution to journal › Comment/Debate › Contributed › peer-review

Contributors

Jens Jordan - , Hannover Medical School (MHH) (Author)
Ali El-Armouche - , Institute of Pharmacology and Toxicology (Author)
Markolf Hanefeld - , GWT-TUD GmbH (Author)
Stefan R. Bornstein - , Department of Internal Medicine III, German Center for Diabetes Research - Paul Langerhans Insitute Dresden (Partner: HMGU), University Hospital Carl Gustav Carus Dresden, German Center for Diabetes Research (DZD e.V.), King's College London (KCL) (Author)
Andreas L. Birkenfeld - , Department of Internal Medicine III, German Center for Diabetes Research - Paul Langerhans Insitute Dresden (Partner: HMGU), University Hospital Carl Gustav Carus Dresden, German Center for Diabetes Research (DZD e.V.), King's College London (KCL), GWT-TUD GmbH (Author)